Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C

Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C

<strong>Background:</strong> Blockade of tumour necrosis factor (anti-TNF) is effective in patients with Crohn’s Disease but has been associated with infection risk and neurological complications such as demyelination. Niemann-Pick disease Type C1 (NPC1) is a lysosomal storage disorder p...

Full description

Bibliographic Details
Main Authors:	Williams, I, Pandey, S, Haller, W, Smith, D, Al Eisa, N, Platt, N, Platt, F, Uhlig, HH, Et al.
Format:	Journal article
Language:	English
Published:	F1000Research 2022

Similar Items

Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C [version 1; peer review: 2 approved]
by: David Smith, et al.
Published: (2022-01-01)

Evaluation of new therapies in Niemann-Pick type C disease
by: Al Eisa, N
Published: (2014)

Unbiased yeast screens identify cellular pathways affected in Niemann–Pick disease type C
by: Colaco, A, et al.
Published: (2020)

Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.
by: Smith, D, et al.
Published: (2009)

Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1
by: David Smith, et al.
Published: (2009-11-01)

Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann–Pick disease type C1 mice
by: Ian M. Williams, et al.
Published: (2014-07-01)

Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
by: Lloyd-Evans, E, et al.
Published: (2010)

A new surrogate marker for CNS pathology in Niemann-Pick disease type C?
by: Platt, F, et al.
Published: (2009)

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
by: Fineran, P, et al.
Published: (2016)

Niemann-Pick disease
by: Serap Karaman, et al.
Published: (2011-03-01)

Niemann-Pick disease
by: Serap Karaman, et al.
Published: (2011-03-01)

Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders.
by: Michael Zech, et al.
Published: (2013-01-01)

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
by: Platt, F, et al.
Published: (2016)

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
by: Platt, F, et al.
Published: (2016)

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
by: Nicoli, E, et al.
Published: (2016)

Differential response of the liver to bile acid treatment in a mouse model of Niemann-Pick disease type C
by: Nicoli, E, et al.
Published: (2017)

Mechanistic convergence and shared therapeutic targets in Niemann‐Pick disease
by: Colaco, A, et al.
Published: (2019)

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
by: te Vruchte, D, et al.
Published: (2004)

Defective platelet function in Niemann‐Pick disease type C1
by: Chen, OCW, et al.
Published: (2020)

Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C
by: Gonzalez-Ortiz, F, et al.
Published: (2024)

Case Report: Ursodeoxycholic acid treatment in Niemann-Pick disease type C; clinical experience in four cases
by: Evans, W, et al.
Published: (2017)

Niemann-Pick disease type C
by: Vanier Marie T
Published: (2010-06-01)

Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.
by: Speak, A, et al.
Published: (2012)

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.
by: Lloyd-Evans, E, et al.
Published: (2008)

Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C.
by: Lachmann, R, et al.
Published: (2004)

Crohn’s disease in Niemann–Pick disease type C1: caught in the cross-fire of host-microbial interactions
by: Cavounidis, A, et al.
Published: (2018)

Niemann - Pick disease associated with hemophagocytic syndrome
by: Serap Karaman, et al.
Published: (2010-12-01)

Niemann - Pick disease associated with hemophagocytic syndrome
by: Serap Karaman, et al.
Published: (2010-12-01)

Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
by: Sandra Torres, et al.
Published: (2017-11-01)

Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann–Pick disease, type C1
by: Julia Yerger, et al.
Published: (2022-04-01)

Difficult diagnosis. Niemann - Pick disease, type C
by: L. S. Namazova-baranova, et al.
Published: (2014-12-01)

Abnormal gangliosides in Tay-Sachs disease, Niemann-Pick's disease, and gargoylism
by: D.A. Booth, et al.
Published: (1966-05-01)

Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
by: Schwerd, T, et al.
Published: (2016)

Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C
by: Robin H Lachmann, et al.
Published: (2004-08-01)

Niemann Pick disease: a rare lysosomal storage disease
by: Gopen Kumar Kundu, et al.
Published: (2023-01-01)

Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1
by: Rodriguez-Gil, J, et al.
Published: (2020)

Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease.
by: Richardson, K, et al.
Published: (2016)

Niemann-Pick type c disease: pathogenesis and therapy
by: Colaco, A
Published: (2016)

A case of Niemann – Pick disease type C
by: Sergei Anatolyevich Klyushnikov, et al.
Published: (2013-12-01)

Molecular basis for a new bovine model of Niemann-Pick type C disease
by: Woolley, SA, et al.
Published: (2020)